Researchers discovered a potent Vitamin A derivative, ATRA, that suppresses growth and induces cell death in childhood brain cancer cells. The gene OTX2 is abnormally amplified in medulloblastoma tumors, which can be targeted by ATRA-based therapy.
Researchers found that smoking promotes rapid production of COX-2 in oral mucosal cells, with tobacco smoke inducing EGFR activation. This activation leads to increased COX-2 protein production, highlighting a potential mechanism for tobacco-related cancers.
A study published in Cancer Research found that BPA exposure can lead to increased cancer cell growth in prostate cancer cells with mutated androgen receptors. This discovery has implications for men diagnosed with BPA-susceptible mutations, who may be at higher risk of cancer progression.
The American Association for Cancer Research (AACR) has awarded scholarships to minority researchers, aiming to increase diversity in the field of cancer research. The recipients, all from underrepresented groups, will receive funding to attend AACR Special Conferences and further their careers.
The American Association for Cancer Research (AACR) has supported nine faculty members from minority-serving institutions with $16,000 awards to attend special conferences in 2004. The winners were chosen by an Advisory Committee and are engaged in meritorious cancer research.
The American Association for Cancer Research (AACR) has recognized and supported 17 women in cancer research this year, providing them with scholarships to attend conferences. The awardees are from various backgrounds, including graduate students, medical students, and postdoctoral fellows.
The American Association for Cancer Research and The V Foundation are awarding $600,000 in grants to four cancer research teams, led by top scientists, to accelerate progress against cancer. The grants will support translational research projects that aim to improve survival and quality of life for patients.
A recent study found that false positive cancer screening test results can lead to substantial medical care costs, affecting both men and women. The research highlights the importance of considering not only the clinical benefits but also potential adverse effects of new screening tests.
Researchers found that green tea polyphenols reduce levels of insulin-like growth factor-1 (IGF-1) in prostate tumor cells, leading to decreased cell survival and tumor growth. The study also showed that GTP inhibited the expression of proteins associated with metastasis and reduced vascular endothelial growth factor (VEGF) levels.
Researchers at Mayo Clinic found that celecoxib reduces mammary gland tumor mass through apoptosis and regulates prostaglandin pathways. The study suggests celecoxib may be used to prevent and treat breast tumors.
A new medication, nitric oxide-donating aspirin, has shown promise in preventing colon cancer by inhibiting the growth of colon cancer cells. The treatment is hundreds to thousands of times more potent than traditional aspirin and may reduce the risk of development by up to 95%.
A multi-center, double-blind study found that patients taking toremifene 20 mg had a lower cumulative incidence of cancer after 12 months, with a 48% reduction compared to placebo. High-grade prostatic intraepithelial neoplasia (PIN) is a precursor to prostate cancer.
A new study reveals that sanguinarine enhances protein production inducing cell death and restricts pro-proliferation proteins, potentially protecting against UV radiation-induced skin cancer. Topical application of sanguinarine with sunscreen may also be effective in preventing skin cancer.
Consuming three or more servings of vegetables daily lowered NHL risk by 40% in study participants. Higher intakes of selenium and zinc also showed protective effects, while vitamins A-C-E and carotenoids had no significant link.
A recent study published by the American Association for Cancer Research found that men with high-grade prostate intraepithelial neoplasia (PIN) are at a higher risk of developing invasive prostate cancer. Within one year, men in the placebo group had a 31.4% risk of being diagnosed with prostate cancer.
A recent study has found that combination hormone therapy doubles breast density and quadruples the risk of abnormal mammograms. The study, led by Anne McTiernan, involved 413 postmenopausal women and showed a significant increase in breast density among older participants.
Allopurinol, commonly used for gout, was found to significantly reduce the risk of colorectal cancer in patients taking the medication for at least five years. The study analyzed data from 1,781 patients and showed a notable reduction in risk.
Researchers found that a class of polyphenols in apples, called procyanidins, significantly reduced precancerous lesions in laboratory animals. The study suggests that consuming whole apples, including the skin, may offer anti-cancer benefits.
A study from Senegal found that urine-based detection of abnormal methylation of three genes provided a sensitivity of 53% and specificity of over 90% for detecting cervical cancer. This approach could have a huge impact on women in developing countries without access to Pap screening.
Researchers found a sharp drop in estrone and estradiol hormone levels with increased dietary fiber intake. A higher intake of dietary fiber was also associated with lower hormone levels even when dietary fat was present.
A new Group Health study examines the link between hormone therapy (HT) and breast density in women of various categories. The study found that estrogen-only therapy increases breast density, while progesterone use does not; longer HT use and older age at first use also increase breast density.
A new study links increased domestic production of betel quid to the incidence of head and neck cancer in Taiwan, with a strong cohort effect observed for men born between 1972-1980. The study suggests a correlation between betel quid usage and head and neck cancer incidence.
Research in British Columbia found a seventeen-fold higher risk of diffuse large B-Cell lymphoma in HCV-infected patients. The study confirmed the viral-cancer link, previously suspected in studies from other regions with higher hepatitis C prevalence.
Researchers found a three-fold increased risk of liver cancer among diabetic patients, which rose to almost four-fold when medication was used. Diabetes did not increase risks for other types of cancer, such as melanoma or colon cancer.
A new study found a link between men's height and their risk level for advanced prostate cancer, with tall men experiencing a 20% increased risk. Additionally, researchers discovered that fruit and vegetable consumption, particularly vitamin C and lycopene, may reduce the risk of stomach cancer by up to 45%.
Dr. David S. Alberts, a renowned cancer researcher, has been honored with the 2004 American Association for Cancer Research (AACR) – Cancer Research and Prevention Foundation Award for Excellence in Cancer Prevention Research. He is recognized for his groundbreaking work on chemoprevention and treatment of various types of cancer.
A new diabody targeting breast tumor growth has been developed, showing significant inhibition of human breast tumor xenografts in mice. The mini-antibody C6.5K-A specifically targets the HER2/neu human tumor-associated antigen and demonstrates great affinity for its target, leading to prolonged retention in antigen-laden tumors.
Researchers found that ovarian cancer tumors lack response to antiestrogens due to decreased ER beta expression, which can lead to increased cell proliferation and apoptosis. The reintroduction of ER beta in cancer cells induced apoptosis, suggesting its regulatory functions in controlling ovarian cancer growth and motility.
A study found that cannabinoids significantly lowered VEGF activity in laboratory mice and patients with late-stage glioblastoma, providing a potential new approach to treating this aggressive form of cancer. The research suggests that cannabinoid-based therapies may target the VEGF pathway, offering a novel pharmacological target.
Researchers found that preschoolers exposed to common childhood infections are less likely to develop Hodgkin's lymphoma in adulthood. This contradicts previous studies linking high socioeconomic status and delayed infection with the Epstein-Barr virus to increased disease risk.
Studies identified 13 mutations on the PIK3CA gene in various types of brain tumors, including anaplastic oligodendrogliomas and glioblastomas. The findings suggest a link between PIK3CA mutations and brain cancer development.
A recent study found that combining EGFR inhibitors like Erbitux with Iressa or Tarceva hinders cancer cell growth more effectively than single drug treatments. The tandem application of these drugs amplified control of cancer cell signaling, leading to increased apoptosis and tumor development limitation.
The American Association for Cancer Research (AACR) is honoring outstanding scientists and physicians who have made significant contributions to cancer research. The AACR recognizes researchers in various fields, including basic cancer research, clinical cancer research, and medical chemistry.
The award honors an individual scientist for highly original research, with the winner receiving €75,000 and a commemorative plaque. Recent past recipients include Stanley J. Korsmeyer and Mario R. Capecchi.
The American Association for Cancer Research is accepting nominations for the 2005 Landon-AACR prizes, which recognize seminal basic and translational cancer research discoveries. The recipient of each prize will receive a $200,000 unrestricted cash award and present a lecture at the 96th AACR Annual Meeting in Anaheim, Calif.
Researchers discovered a synthetic peptide that mimics a protein linkage crucial for melanoma cell migration and angiogenesis. The peptide inhibits this interaction, significantly deterring tumor cell growth and formation of new blood vessels.
Researchers find that combining discodermolide and paclitaxel inhibits human lung cancer cell growth by 41 percent, while alone the drugs exert only 9.6% or 16% growth inhibition. The combination also induces programmed cell death in cancer cells, suggesting a potential therapeutic approach for reducing undesirable side effects.
Researchers developed a novel vaccine by fusing patients' tumor cells with their immune system dendritic cells, resulting in increased T cell response against tumor cells. The treatment showed promise in reducing tumor growth and metastasis in late-stage cancer patients, with some experiencing significant regression of tumors.
Research shows that children who survive ALL have a higher rate of genetic mutations, which can lead to increased risk of developing secondary malignant neoplasms and other complications. The study found that the number of genetic mutations accumulated over the course of treatment and remained elevated after completion.
A new RNAi delivery system has been developed to target brain cancer cells, using antibodies to cross the blood-brain barrier. The treatment has shown promising results in mice with brain tumors, increasing survival time by almost twice as much as a control group.
A year-long study found that postmenopausal women who exercised regularly had significantly lower serum estrogen levels and a reduced risk of breast cancer. The exercise program resulted in a 16.7% reduction in free serum estradiol, a key female sex steroid.
A new small molecule drug, CX-3543, effectively reduces cMyc mRNA expression in colorectal tumor animal models, inhibiting growth of prostate and pancreatic tumors. Sun exposure is linked to a 53% reduced risk of non-Hodgkin lymphoma, with higher childhood outdoor time showing the greatest benefit.
Researchers discovered that Nembutal suppresses colon cancer metastasis and improves post-radiation brain function. Additionally, erythropoietin was found to protect cognitive function after whole brain irradiation, while a new vitamin B12 molecule targets tumor cells.
A study found that the anti-inflammatory drug nimesulide triggered angiogenesis and increased pancreatic cancer cell growth in COX-2 negative tumor cells, but inhibited tumor growth in COX-2 positive cells. Researchers plan to test other COX-2 inhibitors for similar effects.
Regular exercise can reduce a woman's risk of endometrial cancer by up to 30-40% and improve breast cancer survival rates. Studies found that moderate physical activity, including walking and household chores, had significant benefits on cancer risk and survival.
Studies show that exposure to environmental carcinogens can cause DNA damage in the womb, increasing cancer risk. The fetus is more susceptible to genetic damage than the mother, highlighting the need for preventive policies.
A new progesterone receptor antagonist may reduce tumor mass in patients with breast cancer, while a plant virus-based vaccine shows promise in preventing cervical and breast cancers. The novel vaccines aim to block the initial infection of HPV viruses that cause these cancers.
Researchers have found that higher serum levels of vitamin E are associated with lower risks of prostate and bladder cancers. In contrast, a diet rich in antioxidants is linked to a reduced risk of breast cancer among women with specific genetic profiles.
New nanotech imaging techniques offer improved precision in detecting tumors, including lymphatic drainage imaging for breast cancer, and molecular fingerprints for prostate and ovarian cancer. These advancements aim to improve diagnosis and treatment options for cancer patients.
The AACR International Scholars in Breast Cancer Research program aims to improve cancer research and clinical care worldwide. Principal Investigators will mentor talented scientists from under-resourced countries, enhancing their skills and knowledge for successful breast cancer research.